Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 1229

1.

Sex differences in the psychopharmacological treatment of depression.

Sramek JJ, Murphy MF, Cutler NR.

Dialogues Clin Neurosci. 2016 Dec;18(4):447-457.

2.

Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns.

Bałkowiec-Iskra E, Mirowska-Guzel DM, Wielgoś M.

Ginekol Pol. 2017;88(1):36-42. doi: 10.5603/GP.a2017.0007.

3.

The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.

Brown HK, Hussain-Shamsy N, Lunsky Y, Dennis CE, Vigod SN.

J Clin Psychiatry. 2017 Jan;78(1):e48-e58. doi: 10.4088/JCP.15r10194.

PMID:
28129495
5.

Effect of Maternal ±Citalopram Exposure on P11 Expression and Neurogenesis in the Mouse Fetal Brain.

King JR, Velasquez JC, Torii M, Bonnin A.

ACS Chem Neurosci. 2017 Jan 13. doi: 10.1021/acschemneuro.6b00339. [Epub ahead of print]

PMID:
28076682
6.

Pharmacokinetics and pharmacogenetics of SSRIs during pregnancy: An observational study.

Pogliani L, Falvella FS, Cattaneo D, Pileri P, Moscatiello AF, Cheli S, Baldelli S, Fabiano V, Cetin I, Clementi E, Zuccotti G.

Ther Drug Monit. 2016 Dec 29. doi: 10.1097/FTD.0000000000000370. [Epub ahead of print]

PMID:
28045861
7.

Neonatal Toxicity From Escitalopram Use In Utero: A Case Report.

Degiacomo J, Luedtke S.

J Pediatr Pharmacol Ther. 2016 Nov-Dec;21(6):522-526. doi: 10.5863/1551-6776-21.6.522.

8.

Validation of maternal recall of early pregnancy medication exposure using prospective diary data.

Sundermann AC, Hartmann KE, Jones SH, Torstenson ES, Velez Edwards DR.

Ann Epidemiol. 2017 Feb;27(2):135-139.e2. doi: 10.1016/j.annepidem.2016.11.015.

PMID:
28012836
9.

Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy.

Nörby U, Forsberg L, Wide K, Sjörs G, Winbladh B, Källén K.

Pediatrics. 2016 Nov;138(5). pii: e20160181.

PMID:
27940758
10.

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.

Jordan S, Morris JK, Davies GI, Tucker D, Thayer DS, Luteijn JM, Morgan M, Garne E, Hansen AV, Klungsøyr K, Engeland A, Boyle B, Dolk H.

PLoS One. 2016 Dec 1;11(12):e0165122. doi: 10.1371/journal.pone.0165122.

12.

Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Ailes EC, Simeone RM, Dawson AL, Petersen EE, Gilboa SM.

Birth Defects Res A Clin Mol Teratol. 2016 Nov;106(11):927-934. doi: 10.1002/bdra.23573.

PMID:
27891779
13.

Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit.

Hudon Thibeault AA, Laurent L, Vo Duy S, Sauvé S, Caron P, Guillemette C, Sanderson JT, Vaillancourt C.

Mol Cell Endocrinol. 2017 Feb 15;442:32-39. doi: 10.1016/j.mce.2016.11.021.

PMID:
27890559
14.

Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan. A nationwide birth cohort study of the Japan Environment and Children's Study.

Nishigori H, Obara T, Nishigori T, Mizuno S, Metoki H, Hoshiai T, Watanabe Z, Sakurai K, Ishikuro M, Tatsuta N, Nishijima I, Fujiwara I, Kuriyama S, Arima T, Nakai K, Yaegashi N; Japan & Environment Children's Study Group..

Congenit Anom (Kyoto). 2016 Nov 23. doi: 10.1111/cga.12202. [Epub ahead of print]

PMID:
27878857
15.

SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.

Bérard A, Sheehy O, Zhao JP, Vinet É, Bernatsky S, Abrahamowicz M.

Br J Clin Pharmacol. 2016 Nov 22. doi: 10.1111/bcp.13194. [Epub ahead of print]

PMID:
27874994
16.

Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.

Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.

JAMA Psychiatry. 2016 Nov 1;73(11):1163-1170. doi: 10.1001/jamapsychiatry.2016.2594.

PMID:
27732704
17.

Maternal environmental risk factors for congenital hydrocephalus: a systematic review.

Kalyvas AV, Kalamatianos T, Pantazi M, Lianos GD, Stranjalis G, Alexiou GA.

Neurosurg Focus. 2016 Nov;41(5):E3.

PMID:
27798989
18.

Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis.

Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K.

Reprod Toxicol. 2016 Dec;66:31-43. doi: 10.1016/j.reprotox.2016.09.013.

PMID:
27667009
19.

Increased symptoms of illness following prenatal stress: Can it be prevented by fluoxetine?

Avitsur R.

Behav Brain Res. 2017 Jan 15;317:62-70. doi: 10.1016/j.bbr.2016.09.021.

PMID:
27633560
20.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Review.

PMID:
27239775
Items per page

Supplemental Content

Loading ...
Support Center